Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of PRO-179 vs Travatan in Healthy Subjects
NCT03965052Phase 1Completed
- Sponsor
- Laboratorios Sophia
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Bristrio in Glaucoma (2 arms), sponsored by Laboratorios Sophia. Primary endpoints: Number of Participants With Adverse Events at 14 days and Eye Comfort Index at Day 11. Started Apr 2019; status: completed.
02
Drugs
Bristrio
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT03965052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965052.